[LINK] Einstein's fridge an example for NICTA?

Chris Maltby chris at sw.oz.au
Tue Dec 12 09:19:38 AEDT 2006

> On 2006/Dec/11, at 8:28 PM, Chris Maltby wrote:
>> The pharmaceutical industry is a case in point - in spite of the
>> rhetoric about drug company R&D, most new drugs are derived from
>> discoveries made in conjunction with research which is not product
>> driven. The rate of discovery of new classes of drugs has dropped
>> since the Reagan research doctrine was introduced - and research
>> into areas considered non-commercial is now conducted largely by
>> charitable foundations.

On Tue, Dec 12, 2006 at 08:50:45AM +1100, Kim Holburn wrote:
> I remember reading about this but can't find anything on it now.
> Do you have any references?

I don't have any to hand. There was a fair amount of discussion about
this in the political debate surrounding the impact of the US FTA
on Australia's Pharmaceutical Benefits Scheme. The industry claims
that high retail prices for drugs is necessary to pay for the costly
R&D they undertake - the counter argument is that the industry spends
more on marketing than R&D (especially pure research). I recall that
this assertion was supported by figures showing a decline in the
rate of discovery of new drug types...


More information about the Link mailing list